| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Epperly Melissa B, is a Chief Financial Officer at Zentalis Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 23 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 17,107 | $43.39 | $742,323.38 | -1.6% | +7.0% | +12.5% | |
| Mar 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $41.67 | $128,482.48 | -1.1% | - | - | |
| Feb 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $37.56 | $115,804.67 | -0.6% | - | - | |
| Jan 4, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.91 | $160,033.81 | -0.3% | - | - | |
| Dec 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 13,684 | $52.18 | $714,059.90 | -0.8% | - | - | |
| Dec 2, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $51.47 | $158,680.78 | -0.3% | - | - | |
| Nov 23, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 3,083 | $46.58 | $143,613.51 | -0.5% | - | - | |
| Apr 7, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 20,000 | $18.00 | $360,000.00 | +7.2% | - | - |